Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

Aberrant amygdala subregion volumes in youth at high risk for bipolar disorder predict antidepressant-induced adverse events

AI Summary
  • High-risk youth exhibit widespread amygdala subregion abnormalities: reduced lateral, medial, central, cortical, corticoamygdaloid volumes; increased basal and accessory basal volumes.
  • Smaller baseline bilateral cortical and left medial nucleus volumes predicted fewer arousal-related adverse events in escitalopram-treated youth.
  • Larger bilateral basal nuclei volumes predicted more arousal-related adverse events with escitalopram, suggesting amygdala subregions as predictive neurostructural markers.
Summarise with AI (MRCPsych/FRANZCP)

J Affect Disord. 2026 Oct 16:122644. doi: 10.1016/j.jad.2026.122644. Online ahead of print.

ABSTRACT

Youth with familial risk for bipolar disorder (BD) and current depression/anxiety are vulnerable to antidepressant-induced adverse events (AE), including mania. The amygdala, implicated in the pathophysiology of mood disorders, may play a key role in these AE. 105 youth with at least one first-degree relative with BD-I and a current depressive/anxiety disorder (high-risk) and 51 healthy controls (HC) underwent baseline MRI to investigate neurostructural risk factors for antidepressant-induced AE. High-risk youth were randomized to either psychotherapy plus escitalopram or psychotherapy plus placebo (2:1) for up to 16 weeks. Clinical efficacy was assessed using the Children’s Depression Rating Scale-Revised and Pediatric Anxiety Rating Scale, and AE were assessed using the Pediatric Adverse Events Rating Scale and Treatment-Emergent Activation and Suicidality Assessment Profile. Baseline amygdala subregion volumes and their associations with the rates of change in clinical symptoms and AE over time were evaluated using linear regression models. Compared to HC, high-risk youth had reduced volumes in left lateral and medial nuclei, bilateral central and cortical nuclei, and bilateral corticoamygdaloid transition area and increased volumes in bilateral basal and accessory basal nuclei. In escitalopram-treated youth, but not those receiving placebo, smaller baseline volumes in bilateral cortical nuclei and left medial nucleus were associated with fewer arousal-related AE. Additionally, larger bilateral basal nuclei volumes at baseline were associated with more arousal-related AE. Widespread amygdala volume abnormalities provide insights into neurobiological mechanisms underlying the development of BD in high-risk youth, and specific subregion volumes may serve as neurostructural markers for predicting antidepressant-induced AE.

PMID:42887787 | DOI:10.1016/j.jad.2026.122644

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD